Trial Profile
Phase IIa trial of oral exenatide capsules [ORMD 0901] for type 2 diabetes mellitus
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 26 Jun 2013
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Jun 2013 Status changed from planning to recruiting, based on information in an Oramed Pharmaceuticals media release reporting that the trial is underway.
- 05 Apr 2013 New trial record